Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.44 |
| ▸ | CHRNG | P07510 | 1/20 | 0.44 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | CHRND | Q07001 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16955599 | 0.82 | CYP3A4 (0.48) | CYP3A4HPGDMAPTCHRNA1CHRNG | |
| SCHEMBL9548006 | 0.79 | PRSS1 (0.52) | HPGDMAPTNPC1ALDH1A1MEN1 | |
| SCHEMBL703716 | 0.78 | HPGD (0.53) | CYP3A4HPGDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL6128400 | 0.78 | CYP3A4 (0.45) | CYP3A4HPGDMAPTCHRNA1CHRNG | |
| SCHEMBL11806224 | 0.76 | GAA (0.43) | CYP3A4HPGDMAPTCHRNA1CHRNG | |
| SCHEMBL2924706 | 0.76 | HPGD (0.54) | CYP3A4HPGDMAPTCHRNA1CHRNG | |
| SCHEMBL16952569 | 0.75 | HPGD (0.42) | CYP3A4HPGDMAPTCHRNA1CHRNG | |
| SCHEMBL16954415 | 0.75 | GAA (0.44) | CYP3A4HPGDMAPTCHRNA1CHRNG | |
| SCHEMBL6112854 | 0.74 | HDAC1 (0.53) | MAPTNPC1ALDH1A1MEN1KMT2A | |
| SCHEMBL29619400 | 0.74 | TSHR (0.65) | HPGDMAPTCHRNA1CHRNGCHRNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253577-A1 | BIODEFENSE AGENTS | BioVersys AG (CH) | 2021-08-19 | — | — | US | disclosed |
| US-20090088584-A1 | PROCESS FOR PREPARING 3, 4-DISUBSTITUTED PHENYLACETIC ACIDS AND NOVEL INTERMEDIATES | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2009-04-02 | — | — | US | disclosed |
| CN-101389602-A | Process for preparing 3, 4-disubstituted phenylacetic acids and novel intermediates | DSM FINE CHEM AUSTRIA GMBH (AT) | 2009-03-18 | — | — | CN | disclosed |
| EP-1986995-A1 | PROCESS FOR PREPARING 3, 4-DISUBSTITUTED PHENYLACETIC ACIDS AND NOVEL INTERMEDIATES | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007096034-A1 | PROCESS FOR PREPARING 3, 4-DISUBSTITUTED PHENYLACETIC ACIDS AND NOVEL INTERMEDIATES | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2007-08-30 | — | — | WO | disclosed |
| EP-0191496-B1 | TRIAZINE DERIVATIVES, A PROCESS FOR PREPARING THE DERIVATIVES, AND HERBICIDES CONTAINING THE DERIVATIVES AS THE EFFECTIVE COMPONENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-10-31 | — | — | EP | disclosed |
| US-4680054-A | Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1987-07-14 | — | — | US | disclosed |
| EP-0191496-A2 | Triazine Derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1986-08-20 | — | — | EP | disclosed |
| US-3954871-A | ANTIARRHYTHMIA, VASODILATOR, HYPOTENSIVE | CONTINENTAL PHARMA (BE) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088584-A1 | PROCESS FOR PREPARING 3, 4-DISUBSTITUTED PHENYLACETIC ACIDS AND NOVEL INTERMEDIATES | PAH, CTRC, DDC | CYP3A4 142/4885HPGD 3894/4885MAPT 3962/4885 |
| US-20210253577-A1 | BIODEFENSE AGENTS | BPGM, DDT, UNG | CYP3A4 2447/4885HPGD 1855/4885MAPT 557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.